Gene Expression in B-1 Cells from Lupus-Prone Mice

References

• Arasappan D, Tong W, Mummaneni P, et al. (2011). Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med, 9, 65
   PubMed Web of Science ®Google Scholar
• Armananzas R, Calvo B, Inza I, et al. (2009). Microarray analysis of autoimmune diseases by machine learning procedures. IEEE Trans Inf Technol Biomed, 13, 341–50
   PubMedGoogle Scholar
• Bauer JW, Petri M, Batliwalla FM, et al. (2009). Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis Rheum, 60, 3098–107
   PubMed Web of Science ®Google Scholar
• Baumgarth N, Tung JW, Herzenberg LA. (2005). Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Springer Semin Immunopathol, 26, 347–62
   PubMed Web of Science ®Google Scholar
• Bolstad BM, Irizarry RA, Astrand M, Speed TP. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185–93
   PubMed Web of Science ®Google Scholar
• Choubey D, Panchanathan R. (2008). Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett, 119, 32–41
   PubMed Web of Science ®Google Scholar
• Croker BA, Lawson BR, Rutschmann S, et al. (2008). Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc Natl Acad Sci U S A, 105, 15028–33
   PubMed Web of Science ®Google Scholar
• Datta B, Li B, Choubey D, Nallur G, Lengyel P. (1996). p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J Biol Chem, 271, 27544–55
   PubMedGoogle Scholar
• Dauphinee M, Tovar Z, Talal N. (1988). B cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum, 31, 642–7
   PubMed Web of Science ®Google Scholar
• Ghosn EE, Yang Y, Tung J, et al. (2008). CD11b expression distinguishes sequential stages of peritoneal B-1 development. Proc Natl Acad Sci U S A, 105, 5195–200
   PubMed Web of Science ®Google Scholar
• Hardy RR. (2006). B-1 B cell development. J Immunol, 177, 2749–54
   PubMed Web of Science ®Google Scholar
• Herzenberg LA, Stall AM, Lalor PA, et al. (1986). The Ly-1 B cell lineage. Immunol Rev, 93, 81–102
   PubMed Web of Science ®Google Scholar
• Hua J, Kirou K, Lee C, Crow MK. (2006). Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum, 54, 1906–16
   PubMed Web of Science ®Google Scholar
• Hueber W, Zeng D, Strober S, Utz PJ. (2004). Interferon-alpha-inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum, 50, 3239–49
   PubMedGoogle Scholar
• Iciek LA, Waldschmidt TJ, Griffiths MM, Brooks KH. (1994). B-1 cells in systemic autoimmune responses: IgM+, Fc epsilon Rdull B cells are lost during chronic graft-versus-host disease but not in murine AIDS or collagen-induced arthritis. Immunol Invest, 23, 293–311
   PubMed Web of Science ®Google Scholar
• Ishida H, Muchamuel T, Sakaguchi S, et al. (1994). Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med, 179, 305–10
   PubMed Web of Science ®Google Scholar
• James JA, Kaufman KM, Farris AD, et al. (1997). An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest, 100, 3019–26
   PubMed Web of Science ®Google Scholar
• Johnstone RW, Trapani JA. (1999). Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol, 19, 5833–8
   PubMedGoogle Scholar
• Katz KC, Gardam MA, Burt J, Conly JM. (2001). A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting. Infect Control Hosp Epidemiol, 22, 219–21
   PubMedGoogle Scholar
• Martin F, Kearney JF. (2000). B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory". Immunol Rev, 175, 70–9
   PubMed Web of Science ®Google Scholar
• Montecino-Rodriguez E, Dorshkind K. (2006). New perspectives in B-1 B cell development and function. Trends Immunol, 27, 428–33
   PubMed Web of Science ®Google Scholar
• Murakami M, Yoshioka H, Shirai T, et al. (1995). Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol, 7, 877–82
   PubMed Web of Science ®Google Scholar
• Nikpour M, Dempsey AA, Urowitz MB, et al. (2008). Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis, 67, 1069–75
   PubMed Web of Science ®Google Scholar
• Novaes e Brito RRNe, Cortez BA, Machado-Santelli GM, et al. (2010). In Vitro and In Vivo Phagocytic Ability of Mouse B-1 Cells. Immunology and Immunogenetics Insights, 31, 31--9
   Google Scholar
• Novaes e Brito RR, De Lorenzo BH, Xander P, et al. (2007). Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice. Lupus, 16, 947–54
   PubMedGoogle Scholar
• O'Garra A, Howard M. (1992). IL-10 production by CD5 B cells. Ann N Y Acad Sci, 651, 182–99
   PubMedGoogle Scholar
• Origgi L, Perego R, Hu C, et al. (1988). Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus. Boll Ist Sieroter Milan, 67, 116–22
   PubMedGoogle Scholar
• Satoh M, Mizutani A, Behney KM, et al. (2003). X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus. Int Immunol, 15, 1117–24
   PubMed Web of Science ®Google Scholar
• Sawalha AH, Jeffries M, Webb R, et al. (2008). Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun, 9, 368–78
   PubMed Web of Science ®Google Scholar
• Schmidt S, Pericak-Vance MA, Sawcer S, et al. (2006). Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis. Genes Immun, 7, 384–92
   PubMedGoogle Scholar
• Seelig HP, Ehrfeld H, Renz M. (1994). Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus. Arthritis Rheum, 37, 1672–83
   PubMedGoogle Scholar
• Sharif MN, Tassiulas I, Hu Y, et al. (2004). IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol, 172, 6476–81
   PubMed Web of Science ®Google Scholar
• Sidman CL, Shultz LD, Hardy RR, et al. (1986). Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science, 232, 1423–5
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Baccala R, Beutler B, Kono DH. (2005). Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol, 23, 307–36
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. (1985). Murine models of systemic lupus erythematosus. Adv Immunol, 37, 269–390
   PubMed Web of Science ®Google Scholar
• Verdolini R, Bugatti L, Giangiacomi M, et al. (2002). Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol, 146, 877–81
   PubMedGoogle Scholar
• Wakeland EK, Liu K, Graham RR, Behrens TW. (2001). Delineating the genetic basis of systemic lupus erythematosus. Immunity, 15, 397–408
   PubMed Web of Science ®Google Scholar
• Watson A, Mazumder A, Stewart M, Balasubramanian S. (1998). Technology for microarray analysis of gene expression. Curr Opin Biotechnol, 9, 609–14
   PubMed Web of Science ®Google Scholar
• Wylie C. (2005). IFITM1-mediated cell repulsion controls the initial steps of germ cell migration in the mouse. Dev Cell, 9, 723–4
   PubMedGoogle Scholar
• Yamauchi M, Hashimoto M, Ichiyama K, et al. (2007). Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells. Int Immunol, 19, 935–42
   PubMedGoogle Scholar